KAPRUKA

#GRTX New Target : USD 12.04 -13.07-17.05 @ 31%-60% -105%

NASDAQ:GRTX   None
New Target : USD 12.04-13.07-17.05

Resistance 4 : USD 12.04
Resistance 3 : USD 10.83
Resistance 2 : USD 10.03
Resistance 1 : USD 09.33

Support 1 : USD 07.28
Support 2 : USD 05.88


Sector: Health Technology
Industry: Pharmaceuticals: Major


Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The firm involves in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. Its product candidate GC4419 reduces severe oral mucositis in patients with head and neck cancer undergoing radiation therapy and also receiving cisplatin, a chemotherapy drug. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.

**Disclaimer - This is not a financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
Do not view this idea as a recommendation for trading or investing. Risk Only What You Can Afford. Always Use a Stop Loss. Past performance is not necessarily a guide to future performance.

I would appreciate your feedback on my analysis.

Cheers
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.